CS-iCCA, A New Clinically Based Staging System for Intrahepatic Cholangiocarcinoma: Establishment and External Validation

医学 肝内胆管癌 内科学 危险系数 队列 置信区间 一致性 阶段(地层学) 单变量分析 比例危险模型 恶性肿瘤 胃肠病学 肿瘤科 多元分析 古生物学 生物
作者
María E. Lozada,Ning Zhang,Weidong Jin,Nicha Wongjarupong,Ju Dong Yang,Molly M. Voss,Kritika Prasai,Dominic Amakye,William S. Harmsen,Sushant Chaudhary,Oliver F. Bathe,Mitesh J. Borad,Tushar Patel,Gregory J. Gores,Terry M. Therneau,Lewis R. Roberts
出处
期刊:The American Journal of Gastroenterology [Lippincott Williams & Wilkins]
卷期号:118 (12): 2173-2183 被引量:3
标识
DOI:10.14309/ajg.0000000000002258
摘要

INTRODUCTION: Intrahepatic cholangiocarcinoma (iCCA) is a primary liver malignancy with poor prognosis. Current prognostic methods are most accurate for patients with surgically resectable disease. However, a significant proportion of patients with iCCA are not surgical candidates. We aimed to develop a generalizable staging system based on clinical variables to determine prognosis of all patients with iCCA. METHODS: The derivation cohort included 436 patients with iCCA seen between 2000 and 2011. For external validation, 249 patients with iCCA seen from 2000 to 2014 were enrolled. Survival analysis was performed to identify prognostic predictors. All-cause mortality was the primary end point. RESULTS: Eastern Cooperative Oncology Group status, tumor number, tumor size, metastasis, albumin, and carbohydrate antigen 19-9 were incorporated into a 4-stage algorithm. Kaplan-Meier estimates for 1-year survival were 87.1% (95% confidence interval [CI] 76.1–99.7), 72.7% (95% CI 63.4–83.4), 48.0% (95% CI 41.2–56.0), and 16% (95% CI 11–23.5), respectively, for stages I, II, III, and IV. Univariate analysis yielded significant differences in risk of death for stages II (hazard ratio [HR] 1.71; 95% CI 1.0–2.8), III (HR 3.32; 95% CI 2.07–5.31), and IV (HR 7.44; 95% CI 4.61–12.01) compared with stage I (reference). Concordance indices showed the new staging system was superior to the TNM staging for predicting mortality in the derivation cohort, P < 0.0001. In the validation cohort, however, the difference between the 2 staging systems was not significant. DISCUSSION: The proposed independently validated staging system uses nonhistopathologic data to successfully stratify patients into 4 stages. This staging system has better prognostic accuracy compared with the TNM staging and can assist physicians and patients in treatment of iCCA.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
凡凡发布了新的文献求助10
刚刚
免疫与代谢研究完成签到,获得积分10
1秒前
jiajiajai发布了新的文献求助10
2秒前
西早07完成签到,获得积分10
2秒前
Meng完成签到,获得积分10
3秒前
Neo完成签到,获得积分10
4秒前
keyaner完成签到,获得积分10
6秒前
童林艳完成签到,获得积分10
6秒前
ECHO完成签到,获得积分10
8秒前
Lucas应助Fang Xianxin采纳,获得10
9秒前
xiaoyao完成签到,获得积分10
10秒前
asss完成签到,获得积分10
10秒前
Y123发布了新的文献求助30
11秒前
LOVER完成签到 ,获得积分10
12秒前
松松完成签到 ,获得积分10
12秒前
14秒前
nater4ver完成签到,获得积分10
15秒前
UU发布了新的文献求助10
17秒前
超帅鸭子完成签到,获得积分10
17秒前
LXZ完成签到,获得积分10
17秒前
依惜完成签到,获得积分10
17秒前
zhaokunfeng关注了科研通微信公众号
17秒前
赫青亦完成签到 ,获得积分10
17秒前
exy完成签到,获得积分10
18秒前
zhaohu47完成签到,获得积分10
19秒前
超帅鸭子发布了新的文献求助10
19秒前
每每反完成签到,获得积分10
21秒前
凡凡完成签到 ,获得积分10
22秒前
23秒前
呆鹅喵喵完成签到,获得积分10
23秒前
忧心的洙完成签到,获得积分10
24秒前
123完成签到,获得积分10
24秒前
青青草完成签到,获得积分10
26秒前
Fang Xianxin完成签到,获得积分20
26秒前
yue发布了新的文献求助10
26秒前
小甘看世界完成签到,获得积分0
28秒前
量子星尘发布了新的文献求助10
28秒前
张今天也要做科研呀完成签到,获得积分10
29秒前
nater3ver完成签到,获得积分10
30秒前
30秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038303
求助须知:如何正确求助?哪些是违规求助? 3576013
关于积分的说明 11374210
捐赠科研通 3305780
什么是DOI,文献DOI怎么找? 1819322
邀请新用户注册赠送积分活动 892672
科研通“疑难数据库(出版商)”最低求助积分说明 815029